| dbo:abstract
|
- Cephalon, Inc. era una empresa biofarmacèutica amb seu a a l'estat de Pennsilvània als Estats Units. La companyia era especialitzada en els camps de la neurologia, analgèsica i oncologia. La companyia va ser creada el 1987 pel neuròleg Frank Baldino. El 2010 va adquirir el fabricant suís de genèrica Mepha del grup Merckle. El 2011 tenia uns 3700 empleats. El 2011 la companyia israeliana Teva, especialista en medicaments genèrics al seu torn va adquirir Cephalon. Tenia una filial a Sant Cugat del Vallès. (ca)
- شركة سيفالون (بالألمانية: Cephalon, Inc.) كانت شركة صيدلانية أمريكية مقرها في ، بنسيلفانيا، استحوذت عليها شركة تيفا في مايو 2011 بصفقة بلغت 6.8 مليار دولار أمريكي. (ar)
- Cephalon, Inc. war ein US-amerikanisches Pharmaunternehmen. Das 1987 gegründete Unternehmen wurde 2011 vom israelischen Pharmakonzern Teva übernommen. (de)
- Cephalon, Inc. was an American biopharmaceutical company co-founded in 1987 by pharmacologist Frank Baldino, Jr., neuroscientist Michael Lewis, and organic chemist James C. Kauer—all three former scientists with the DuPont Company. Baldino served as Cephalon's chairman and chief executive officer, until his death in December 2010. The company's name comes from the adjective "cephalic" meaning "related to the head or brain", as it was established primarily to pursue treatments for neurodegenerative diseases. As noted by fundinguniverse.com, in its early years, "Cephalon initially avoided involving itself in activities that would require maintaining a sales staff, managing clinical trials, and shepherding new drugs through the Food and Drug Administration (FDA) approval process. With no product to sell, Cephalon's only asset was its scientific expertise. That expertise proved sufficient to attract investors, and the company managed to fund its operations through research grants and contracts with larger pharmaceutical firms." Cephalon was first included in the Fortune 1000 list of U.S. companies based upon annual revenues for 2006. Sales revenues reached $2.8 billion in 2010, ranking Cephalon among the leading biopharmaceutical companies in the world at that time. On May 2, 2011, Teva Pharmaceutical Industries announced it would acquire Cephalon. (en)
- Cephalon est une entreprise américaine filiale de la société israélienne Teva Pharmaceutical Industries. Elle fait partie de l'indice NASDAQ-100 (fr)
|
| dbo:foundedBy
| |
| dbo:foundingYear
| |
| dbo:industry
| |
| dbo:numberOfEmployees
|
- 3726 (xsd:nonNegativeInteger)
|
| dbo:product
| |
| dbo:type
| |
| dbo:wikiPageExternalLink
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 14447 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:founder
|
- Michael Lewis (en)
- * Frank Baldino (en)
- James C. Kauer (en)
|
| dbp:homepage
| |
| dbp:industry
| |
| dbp:keyPeople
| |
| dbp:name
| |
| dbp:numEmployees
|
- 0001-12-31 (xsd:gMonthDay)
|
| dbp:products
|
- alertness drug Provigil, the painkiller Actiq, seizure medication Gabitril (en)
|
| dbp:type
|
- Subsidiary of Teva Pharmaceutical Industries (en)
|
| dbp:wikiPageUsesTemplate
| |
| dbp:wordnet_type
| |
| dcterms:subject
| |
| rdf:type
| |
| rdfs:comment
|
- Cephalon, Inc. era una empresa biofarmacèutica amb seu a a l'estat de Pennsilvània als Estats Units. La companyia era especialitzada en els camps de la neurologia, analgèsica i oncologia. La companyia va ser creada el 1987 pel neuròleg Frank Baldino. El 2010 va adquirir el fabricant suís de genèrica Mepha del grup Merckle. El 2011 tenia uns 3700 empleats. El 2011 la companyia israeliana Teva, especialista en medicaments genèrics al seu torn va adquirir Cephalon. Tenia una filial a Sant Cugat del Vallès. (ca)
- شركة سيفالون (بالألمانية: Cephalon, Inc.) كانت شركة صيدلانية أمريكية مقرها في ، بنسيلفانيا، استحوذت عليها شركة تيفا في مايو 2011 بصفقة بلغت 6.8 مليار دولار أمريكي. (ar)
- Cephalon, Inc. war ein US-amerikanisches Pharmaunternehmen. Das 1987 gegründete Unternehmen wurde 2011 vom israelischen Pharmakonzern Teva übernommen. (de)
- Cephalon est une entreprise américaine filiale de la société israélienne Teva Pharmaceutical Industries. Elle fait partie de l'indice NASDAQ-100 (fr)
- Cephalon, Inc. was an American biopharmaceutical company co-founded in 1987 by pharmacologist Frank Baldino, Jr., neuroscientist Michael Lewis, and organic chemist James C. Kauer—all three former scientists with the DuPont Company. Baldino served as Cephalon's chairman and chief executive officer, until his death in December 2010. The company's name comes from the adjective "cephalic" meaning "related to the head or brain", as it was established primarily to pursue treatments for neurodegenerative diseases. As noted by fundinguniverse.com, in its early years, (en)
|
| rdfs:label
|
- سيفالون (ar)
- Cephalon, Inc. (ca)
- Cephalon (Unternehmen) (de)
- Cephalon (en)
- Cephalon (fr)
|
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:homepage
| |
| foaf:isPrimaryTopicOf
| |
| foaf:name
| |
| is dbo:wikiPageDisambiguates
of | |
| is dbo:wikiPageRedirects
of | |
| is dbo:wikiPageWikiLink
of | |
| is foaf:primaryTopic
of | |
